Application of Big Data and Artificial Intelligence in COVID-19 Prevention, Diagnosis, Treatment and Management Decisions in China.

Jiancheng Dong, Huiqun Wu, Dong Zhou, Kaixiang Li, Yuanpeng Zhang, Hanzhen Ji, Zhuang Tong, Shuai Lou, Zhangsuo Liu
Author Information
  1. Jiancheng Dong: Medical Big Data Research Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. dongjc@ntu.edu.cn. ORCID
  2. Huiqun Wu: Department of Medical Informatics, Medical School of Nantong University, Nantong, China.
  3. Dong Zhou: Department of Medical Informatics, Medical School of Nantong University, Nantong, China.
  4. Kaixiang Li: Medical Big Data Research Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  5. Yuanpeng Zhang: Department of Medical Informatics, Medical School of Nantong University, Nantong, China.
  6. Hanzhen Ji: The Third Affiliated Hospital of Nantong University, Nantong, China.
  7. Zhuang Tong: Medical Big Data Research Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  8. Shuai Lou: Jiangsu Zhongkang Software Co, Ltd, Nantong, China.
  9. Zhangsuo Liu: Medical Big Data Research Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. zhangsuoliu@zzu.edu.cn.

Abstract

COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), spread rapidly and affected most of the world since its outbreak in Wuhan, China, which presents a major challenge to the emergency response mechanism for sudden public health events and epidemic prevention and control in all countries. In the face of the severe situation of epidemic prevention and control and the arduous task of social management, the tremendous power of science and technology in prevention and control has emerged. The new generation of information technology, represented by big data and artificial intelligence (AI) technology, has been widely used in the prevention, diagnosis, treatment and management of COVID-19 as an important basic support. Although the technology has developed, there are still challenges with respect to epidemic surveillance, accurate prevention and control, effective diagnosis and treatment, and timely judgement. The prevention and control of sudden infectious diseases usually depend on the control of infection sources, interruption of transmission channels and vaccine development. Big data and AI are effective technologies to identify the source of infection and have an irreplaceable role in distinguishing close contacts and suspicious populations. Advanced computational analysis is beneficial to accelerate the speed of vaccine research and development and to improve the quality of vaccines. AI provides support in automatically processing relevant data from medical images and clinical features, tests and examination findings; predicting disease progression and prognosis; and even recommending treatment plans and strategies. This paper reviews the application of big data and AI in the COVID-19 prevention, diagnosis, treatment and management decisions in China to explain how to apply big data and AI technology to address the common problems in the COVID-19 pandemic. Although the findings regarding the application of big data and AI technologies in sudden public health events lack validation of repeatability and universality, current studies in China have shown that the application of big data and AI is feasible in response to the COVID-19 pandemic. These studies concluded that the application of big data and AI technology can contribute to prevention, diagnosis, treatment and management decision making regarding sudden public health events in the future.

Keywords

References

  1. Chest. 2021 Jan;159(1):270-281 [PMID: 32653568]
  2. JAMA. 2020 Apr 7;323(13):1239-1242 [PMID: 32091533]
  3. CA Cancer J Clin. 2019 Mar;69(2):127-157 [PMID: 30720861]
  4. Int J Biol Sci. 2020 Mar 15;16(10):1708-1717 [PMID: 32226288]
  5. JAMA. 2020 Aug 25;324(8):782-793 [PMID: 32648899]
  6. JAMA. 2020 Sep 8;324(10):951-960 [PMID: 32789505]
  7. Front Immunol. 2020 Jul 03;11:1581 [PMID: 32719684]
  8. J Bioinform Comput Biol. 2020 Feb;18(1):2040002 [PMID: 32336247]
  9. Viruses. 2020 Sep 12;12(9): [PMID: 32932748]
  10. Zhongguo Zhong Yao Za Zhi. 2020 Apr;45(7):1521-1525 [PMID: 32489029]
  11. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 May 25;49(2):260-269 [PMID: 32391675]
  12. Front Artif Intell. 2020 May;3: [PMID: 33184612]
  13. J Med Eng Technol. 2020 Aug;44(6):267-283 [PMID: 32498594]
  14. Am J Chin Med. 2020;48(4):763-777 [PMID: 32349517]
  15. Acta Pharm Sin B. 2020 Jul;10(7):1149-1162 [PMID: 32834946]
  16. Zhongguo Zhong Yao Za Zhi. 2020 Apr;45(7):1526-1530 [PMID: 32489030]
  17. N Engl J Med. 2020 Apr 30;382(18):1708-1720 [PMID: 32109013]
  18. JAMA Intern Med. 2020 Aug 1;180(8):1081-1089 [PMID: 32396163]
  19. J Med Syst. 2020 Jan 8;44(2):52 [PMID: 31915982]
  20. Lancet. 2020 Mar 28;395(10229):1054-1062 [PMID: 32171076]
  21. JMIR Med Inform. 2020 Jun 8;8(6):e19515 [PMID: 32479411]
  22. Radiology. 2021 Apr;299(1):E167-E176 [PMID: 33231531]
  23. AJR Am J Roentgenol. 2020 May;214(5):1137-1138 [PMID: 32130042]
  24. J Med Internet Res. 2020 Jan 7;22(1):e16377 [PMID: 31909724]
  25. Biosens Bioelectron. 2020 Oct 1;165:112412 [PMID: 32729531]
  26. BMJ. 2020 Feb 19;368:m606 [PMID: 32075786]
  27. J Med Internet Res. 2020 May 8;22(5):e19577 [PMID: 32349962]
  28. Nature. 2020 Oct;586(7830):572-577 [PMID: 32726802]
  29. Chin J Integr Med. 2020 Apr;26(4):243-250 [PMID: 32065348]
  30. Viruses. 2020 Feb 25;12(3): [PMID: 32106567]
  31. Radiology. 2020 Aug;296(2):E65-E71 [PMID: 32191588]
  32. Zhonghua Yu Fang Yi Xue Za Zhi. 2020 Jun 6;54(6):602-607 [PMID: 32842277]
  33. Chin J Nat Med. 2020 Mar;18(3):206-210 [PMID: 32245590]
  34. Aust N Z J Public Health. 2020 Dec;44(6):502-507 [PMID: 33044796]
  35. J Med Virol. 2020 Jun;92(6):540-545 [PMID: 32108352]
  36. Expert Opin Drug Discov. 2020 Nov;15(11):1267-1281 [PMID: 32662677]
  37. J Epidemiol Glob Health. 2020 Jun;10(2):118-123 [PMID: 32538026]
  38. BMC Infect Dis. 2020 Sep 29;20(1):710 [PMID: 32993524]
  39. Syst Rev. 2020 Aug 3;9(1):170 [PMID: 32746913]
  40. Int J Environ Res Public Health. 2020 Jul 24;17(15): [PMID: 32722154]
  41. Curr Pharm Des. 2020;26(26):3069-3075 [PMID: 32228416]
  42. Infect Dis Poverty. 2020 Sep 16;9(1):130 [PMID: 32938502]
  43. IEEE Trans Nanobioscience. 2020 Jul;19(3):579-587 [PMID: 32603300]
  44. Curr Opin Ophthalmol. 2020 Sep;31(5):318-323 [PMID: 32657996]
  45. J Med Internet Res. 2020 Oct 27;22(10):e21476 [PMID: 32946413]
  46. Emerg Microbes Infect. 2020 Dec;9(1):687-690 [PMID: 32208840]
  47. Lancet. 2020 Aug 15;396(10249):479-488 [PMID: 32702299]
  48. Arab J Sci Eng. 2020;45(12):9895-9911 [PMID: 33072472]
  49. Int J Med Inform. 2020 May;137:104100 [PMID: 32088557]
  50. Lancet Digit Health. 2020 Dec;2(12):e667-e676 [PMID: 32984792]
  51. Infect Dis Poverty. 2020 Jul 6;9(1):83 [PMID: 32631426]
  52. Cell. 2020 Jun 11;181(6):1423-1433.e11 [PMID: 32416069]
  53. BMJ. 2020 Apr 7;369:m1328 [PMID: 32265220]
  54. Nature. 2009 Feb 19;457(7232):1012-4 [PMID: 19020500]
  55. Int Immunopharmacol. 2020 Nov;88:106928 [PMID: 32862110]
  56. Integr Med Res. 2020 Sep;9(3):100434 [PMID: 32632356]
  57. J Med Internet Res. 2019 Nov 27;21(11):e16272 [PMID: 31774409]
  58. Biomed Pharmacother. 2020 Sep;129:110281 [PMID: 32554251]
  59. Bull World Health Organ. 2020 Apr 1;98(4):263-269 [PMID: 32284650]
  60. JMIR Med Inform. 2020 Jul 14;8(7):e19866 [PMID: 32568725]
  61. Science. 2020 May 29;368(6494):948-950 [PMID: 32393526]
  62. Nat Commun. 2020 Jul 15;11(1):3543 [PMID: 32669540]
  63. Lancet. 2020 Jun 13;395(10240):1845-1854 [PMID: 32450106]
  64. Phytomedicine. 2021 May;85:153364 [PMID: 33041173]
  65. Zhongguo Zhong Yao Za Zhi. 2020 Mar;45(6):1232-1241 [PMID: 32281330]
  66. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Oct;32(10):1155-1159 [PMID: 33198854]
  67. Cell. 2020 Aug 6;182(3):734-743.e5 [PMID: 32643603]
  68. Front Med. 2020 Oct;14(5):529-532 [PMID: 32705405]
  69. J Mark Access Health Policy. 2020 Oct 8;8(1):1818446 [PMID: 33133431]
  70. Front Med. 2020 Apr;14(2):199-209 [PMID: 32279219]
  71. Nat Commun. 2020 Aug 14;11(1):4081 [PMID: 32796842]
  72. Front Med. 2020 Oct;14(5):681-688 [PMID: 32651936]
  73. Curr Genet Med Rep. 2019 Dec;7(4):208-213 [PMID: 31871830]
  74. China CDC Wkly. 2020 Feb 21;2(8):113-122 [PMID: 34594836]
  75. Eur J Drug Metab Pharmacokinet. 2020 Dec;45(6):761-770 [PMID: 32930952]
  76. Science. 2020 May 29;368(6494):945-946 [PMID: 32385100]
  77. Pharmacogenomics. 2020 Jan;21(2):141-156 [PMID: 31950879]
  78. Zhonghua Yu Fang Yi Xue Za Zhi. 2020 Jun 6;54(6):620-624 [PMID: 32125133]
  79. Am J Chin Med. 2020;48(5):1035-1049 [PMID: 32668970]
  80. Zhongguo Zhong Yao Za Zhi. 2020 Mar;45(6):1248-1252 [PMID: 32281332]
  81. Eur Respir J. 2020 May 14;55(5): [PMID: 32217650]
  82. Eur Respir J. 2020 Aug 20;56(2): [PMID: 32616597]
  83. Science. 2014 Mar 14;343(6176):1203-5 [PMID: 24626916]
  84. Mil Med Res. 2020 Sep 4;7(1):41 [PMID: 32887670]
  85. World J Pediatr. 2020 Jun;16(3):232-239 [PMID: 32333248]
  86. Eur J Public Health. 2019 Oct 1;29(Supplement_3):23-27 [PMID: 31738444]
  87. Nat Med. 2019 Jan;25(1):24-29 [PMID: 30617335]
  88. Adv Exp Med Biol. 2020;1213:3-21 [PMID: 32030660]
  89. J Ethnopharmacol. 2020 Aug 10;258:112932 [PMID: 32376368]
  90. J Healthc Eng. 2020 Aug 30;2020:8894694 [PMID: 32952992]
  91. IEEE Trans Ultrason Ferroelectr Freq Control. 2020 Nov;67(11):2241-2248 [PMID: 32881685]
  92. Lancet. 2020 Apr 18;395(10232):1230 [PMID: 32305082]
  93. Infect Dis Poverty. 2020 Aug 24;9(1):116 [PMID: 32831142]
  94. Am J Med Qual. 2020 Jul/Aug;35(4):341-348 [PMID: 31581790]
  95. J Am Med Inform Assoc. 2020 Jun 1;27(6):934-938 [PMID: 32447373]
  96. Front Genet. 2019 Nov 28;10:1191 [PMID: 31850062]
  97. Carbohydr Polym. 2020 Jul 15;240:116346 [PMID: 32475597]
  98. Comput Math Methods Med. 2017;2017:6120820 [PMID: 29375652]
  99. Syst Rev. 2020 Apr 8;9(1):75 [PMID: 32268923]
  100. Nature. 2020 Mar;579(7798):265-269 [PMID: 32015508]

MeSH Term

Artificial Intelligence
Big Data
COVID-19
China
Humans
Pandemics
SARS-CoV-2

Word Cloud

Created with Highcharts 10.0.0preventiondataAICOVID-19controltechnologybigtreatmentChinasuddenmanagementdiagnosisapplicationpublichealtheventsepidemicBigsevereresponseintelligencesupportAlthougheffectiveinfectionvaccinedevelopmenttechnologiesfindingspandemicregardingstudiesArtificialcausedacuterespiratorysyndromecoronavirus2SARS-CoV-2spreadrapidlyaffectedworldsinceoutbreakWuhanpresentsmajorchallengeemergencymechanismcountriesfacesituationarduoustasksocialtremendouspowerscienceemergednewgenerationinformationrepresentedartificialwidelyusedimportantbasicdevelopedstillchallengesrespectsurveillanceaccuratetimelyjudgementinfectiousdiseasesusuallydependsourcesinterruptiontransmissionchannelsidentifysourceirreplaceableroledistinguishingclosecontactssuspiciouspopulationsAdvancedcomputationalanalysisbeneficialacceleratespeedresearchimprovequalityvaccinesprovidesautomaticallyprocessingrelevantmedicalimagesclinicalfeaturestestsexaminationpredictingdiseaseprogressionprognosisevenrecommendingplansstrategiespaperreviewsdecisionsexplainapplyaddresscommonproblemslackvalidationrepeatabilityuniversalitycurrentshownfeasibleconcludedcancontributedecisionmakingfutureApplicationDataIntelligencePreventionDiagnosisTreatmentManagementDecisionsDeeplearningEpidemic

Similar Articles

Cited By (19)